| Breast Carcinoma altered in cohorts of …ALTERED_INderived200 of 276show all (up to 200) |
|---|
| ← altered in cohorts of | OBSCN 806 / 1,098 cases (73 %) · ssm · TCGA-BRCA · largest of 3 cohorts | — | — | Breast Invasive Carcinoma, NOS | 3 | Observed | gdc | graph → |
| ← altered in cohorts of | PIK3C2B 804 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRN2 803 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MDM4 803 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NFASC 803 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NID1 803 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PLEKHA6 802 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP1R15B 801 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ASPM 800 / 1,098 cases (73 %) · ssm · TCGA-BRCA · largest of 2 cohorts | — | — | Breast Invasive Carcinoma, NOS | 2 | Observed | gdc | graph → |
| ← altered in cohorts of | CDK18 800 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHI3L1 799 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CNTN2 799 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DSTYK 799 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EXOC8 799 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LYST 799 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC35F3 799 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMCC2 799 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM81 799 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ATP2B4 798 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BLACAT1 798 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GNPAT 798 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GOLT1A 798 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KISS1 798 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LEMD1 798 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NUAK2 798 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RAB29 798 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBBP5 798 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZC3H11A 798 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C1orf131 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DISC1 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ETNK2 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FCMR 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IRF2BP2 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHDC8A 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MFSD4A 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NUCKS1 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PFKFB2 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PIGR 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | REN 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC26A9 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC41A1 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SOX13 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SPRTN 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TOMM20 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRIM67 797 / 1,098 cases (73 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADIPOR1 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARID4B 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COA6 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYB5R1 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EGLN1 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ELK4 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ESRRG 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FAM89A 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FMOD 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GALNT2 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HEATR1 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNT2 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KLHL12 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PCNX2 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PM20D1 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PRELP 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RBM34 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SIPA1L2 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC45A3 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SYT2 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TBCE 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TMEM183A 796 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARV1 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | B3GALNT2 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BTG2 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C1orf116 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C4BPB 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CDC42BPA 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CFH 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CHIT1 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DENND1B 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DNAH14 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ENAH 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FCAMR 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GNG4 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IKBKE 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL19 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL20 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IL24 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LAX1 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LBR 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAP10 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYBPH 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OPTC 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPFIA4 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PSEN2 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SNRPE 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TARBP1 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TTC13 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | YOD1 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBED6 795 / 1,098 cases (72 %) · ssm · TCGA-BRCA | — | — | Breast Invasive Carcinoma, NOS | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TP53 1,707 / 3,879 cases (44 %) · ssm · breast_msk_2025 · largest of 23 cohorts | — | — | Invasive Breast Carcinoma | 23 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PIK3CA 1,401 / 3,879 cases (36 %) · ssm · breast_msk_2025 · largest of 19 cohorts | — | — | Invasive Breast Carcinoma | 19 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VPS13B 30 / 134 cases (22 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ABCD4 24 / 116 cases (21 %) · ssm · brca_bccrc_xenograft_2014 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SHOC2 24 / 116 cases (21 %) · ssm · brca_bccrc_xenograft_2014 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE2 27 / 134 cases (20 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | HUWE1 26 / 134 cases (19 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC19 26 / 134 cases (19 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NEB 26 / 134 cases (19 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAM47C 22 / 116 cases (19 %) · ssm · brca_bccrc_xenograft_2014 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KALRN 22 / 116 cases (19 %) · ssm · brca_bccrc_xenograft_2014 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DST 25 / 134 cases (19 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | LRTM3 25 / 134 cases (19 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DYNC1H1 24 / 134 cases (18 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RUNX1T1 24 / 134 cases (18 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TTN 187 / 1,066 cases (18 %) · ssm · brca_tcga_pan_can_atlas_2018 · largest of 13 cohorts | — | — | Invasive Breast Carcinoma | 13 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF415 20 / 116 cases (17 %) · ssm · brca_bccrc_xenograft_2014 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BLTP1 23 / 134 cases (17 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH15 23 / 134 cases (17 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAT1 89 / 527 cases (17 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MUC16 409 / 2,433 cases (17 %) · ssm · brca_metabric · largest of 9 cohorts | — | — | Invasive Breast Carcinoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SPEN 88 / 527 cases (17 %) · ssm · brca_msk_2025 · largest of 2 cohorts | — | — | Invasive Breast Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TCHH 22 / 134 cases (16 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VPS13D 22 / 134 cases (16 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK2 395 / 2,433 cases (16 %) · ssm · brca_metabric | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FAM186A 21 / 134 cases (16 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MACF1 21 / 134 cases (16 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MYH9 21 / 134 cases (16 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PKHD1L1 21 / 134 cases (16 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TCF20 21 / 134 cases (16 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | UBR5 21 / 134 cases (16 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WDFY4 21 / 134 cases (16 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GATA3 582 / 3,879 cases (15 %) · ssm · breast_msk_2025 · largest of 12 cohorts | — | — | Invasive Breast Carcinoma | 12 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZFHX3 73 / 488 cases (15 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ADGRV1 20 / 134 cases (15 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL12A1 20 / 134 cases (15 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PRKDC 20 / 134 cases (15 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TPR 20 / 134 cases (15 %) · ssm · brca_aurora_2023 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CDH1 566 / 3,879 cases (15 %) · ssm · breast_msk_2025 · largest of 10 cohorts | — | — | Invasive Breast Carcinoma | 10 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2B 57 / 407 cases (14 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MGA 66 / 488 cases (14 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRCA2 70 / 527 cases (13 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | IGDCC4 50 / 379 cases (13 %) · ssm · brca_mbcproject_2022 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATM 69 / 527 cases (13 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2A 68 / 527 cases (13 %) · ssm · brca_msk_2025 · largest of 2 cohorts | — | — | Invasive Breast Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SYNE1 294 / 2,433 cases (12 %) · ssm · brca_metabric · largest of 6 cohorts | — | — | Invasive Breast Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATRX 61 / 527 cases (12 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | APC 60 / 527 cases (11 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ATR 59 / 527 cases (11 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RB1 54 / 527 cases (10 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ROS1 54 / 527 cases (10 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SETD2 54 / 527 cases (10 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1B 53 / 527 cases (10 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH4 53 / 527 cases (10 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ESR1 388 / 3,879 cases (10 %) · ssm · breast_msk_2025 · largest of 4 cohorts | — | — | Invasive Breast Carcinoma | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | JAK1 52 / 527 cases (9.9 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NSD1 52 / 527 cases (9.9 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZKSCAN1 37 / 379 cases (9.8 %) · ssm · brca_mbcproject_2022 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB2 51 / 527 cases (9.7 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MTOR 51 / 527 cases (9.7 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GIMAP6 36 / 379 cases (9.5 %) · ssm · brca_mbcproject_2022 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH11 226 / 2,433 cases (9.3 %) · ssm · brca_metabric | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2C 357 / 3,879 cases (9.2 %) · ssm · breast_msk_2025 · largest of 9 cohorts | — | — | Invasive Breast Carcinoma | 9 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53BP1 37 / 407 cases (9.1 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | AHNAK 220 / 2,433 cases (9.0 %) · ssm · brca_metabric | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID2 46 / 527 cases (8.7 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ANKRD11 42 / 488 cases (8.6 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SLX4 35 / 407 cases (8.6 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CREBBP 45 / 527 cases (8.5 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MAP2K4 45 / 527 cases (8.5 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TET1 44 / 527 cases (8.3 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BRCA1 43 / 527 cases (8.2 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH2 43 / 527 cases (8.2 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MAP3K1 314 / 3,879 cases (8.1 %) · ssm · breast_msk_2025 · largest of 8 cohorts | — | — | Invasive Breast Carcinoma | 8 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRD 42 / 527 cases (8.0 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTEN 303 / 3,879 cases (7.8 %) · ssm · breast_msk_2025 · largest of 6 cohorts | — | — | Invasive Breast Carcinoma | 6 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RYR1 29 / 379 cases (7.7 %) · ssm · brca_mbcproject_2022 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH2 186 / 2,433 cases (7.6 %) · ssm · brca_metabric | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | INPPL1 31 / 407 cases (7.6 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | EP300 40 / 527 cases (7.6 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB3 40 / 527 cases (7.6 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | MDC1 40 / 527 cases (7.6 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TSC2 40 / 527 cases (7.6 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | FGFR4 39 / 527 cases (7.4 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRT 39 / 527 cases (7.4 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TET2 39 / 527 cases (7.4 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ZNF208 28 / 379 cases (7.4 %) · ssm · brca_mbcproject_2022 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KMT2D 176 / 2,433 cases (7.2 %) · ssm · brca_metabric · largest of 2 cohorts | — | — | Invasive Breast Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | GRIN2A 38 / 527 cases (7.2 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KDM5C 38 / 527 cases (7.2 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SMAD4 38 / 527 cases (7.2 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SMARCA4 38 / 527 cases (7.2 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ARID1A 279 / 3,879 cases (7.2 %) · ssm · breast_msk_2025 · largest of 2 cohorts | — | — | Invasive Breast Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CSMD3 27 / 379 cases (7.1 %) · ssm · brca_mbcproject_2022 · largest of 2 cohorts | — | — | Invasive Breast Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CARD11 37 / 527 cases (7.0 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CIC 37 / 527 cases (7.0 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ERBB4 37 / 527 cases (7.0 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPRS 37 / 527 cases (7.0 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RICTOR 37 / 527 cases (7.0 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | USH2A 170 / 2,433 cases (7.0 %) · ssm · brca_metabric · largest of 7 cohorts | — | — | Invasive Breast Carcinoma | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PREX2 28 / 407 cases (6.9 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNAH5 167 / 2,433 cases (6.9 %) · ssm · brca_metabric · largest of 3 cohorts | — | — | Invasive Breast Carcinoma | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH1 35 / 527 cases (6.6 %) · ssm · brca_msk_2025 · largest of 2 cohorts | — | — | Invasive Breast Carcinoma | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NOTCH3 35 / 527 cases (6.6 %) · ssm · brca_msk_2025 | — | — | Invasive Breast Carcinoma | 1 | Observed | cbioportal | graph → |